Neurogenetics, Part II

<p>Section V.  Dementias<br>26. The genetic landscape of Alzheimer disease<br>27. Frontotemporal dementia<br>28. The genetics of dementia with Lewy bodies<br>29. Prion disease</p> <p>Section VI.  Paroxysmal Disorders<br>30. Genetics of epilepsy<br>31. Genetics of migraine<br>32. Periodic paralysis<br>33. Episodic ataxias<br>34. Disorders of sleep and circadian rhythms</p> <p>Section VII.  Neuromuscular Disorders<br>35. Facioscapulohumeral muscular dystrophy<br>36. The genetics of congenital myopathies<br>37. Genetic basis and phenotypic features of congenital myasthenic syndromes<br>38. Spinal muscular atrophy<br>39. Emerging understanding of the genotype:  Phenotype relationship in amyotrophic lateral sclerosis<br>40. Spinal and bulbar muscular atrophy<br>41. Hereditary spastic paraplegia<br>42. Neuropathy</p> <p>Section VIII.  Diseases of White Matter and Demyelination <br>43. The spectrum of adult-onset heritable white matter disorders <br>44. Alexander disease<br>45. Neurogenetics of Pelizaeus-Merzbacher disease<br>46. Multiple sclerosis </p> <p>Section IX.  Cerebrovascular Diseases<br>47. CADASIL</p> <p>Section X.  Major Adult Psychiatric Disorders<br>48. Neuroepigenetics and addiction<br>49. Genetic susceptibility in obsessive-compulsive disorder</p> <p>Section XI.  Cancer and Phakomatoses<br>50. Brain cancer genomics and epigenomics<br>51. Neurofibromatosis type 1<br>52. Tuberous sclerosis complex<br>53. Von Hippel-Lindau disease and Sturge-Weber syndrome</p>